Patents by Inventor Jean-Pierre Cole

Jean-Pierre Cole has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190069816
    Abstract: Methods and devices for providing application specific integrated circuit architecture for a two electrode analyte sensor or a three electrode analyte sensor are provided. Systems and kits employing the same are also provided.
    Type: Application
    Filed: April 24, 2018
    Publication date: March 7, 2019
    Inventors: Jean-Pierre Cole, Martin J. Fennell
  • Patent number: 10213141
    Abstract: Systems, devices, and methods are provided for changing the power state of a sensor control device in an in vivo analyte monitoring system in various manners, such as through the use of external stimuli (light, magnetics) and RF transmissions.
    Type: Grant
    Filed: April 29, 2014
    Date of Patent: February 26, 2019
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Jean-Pierre Cole, Lei He, Michael R. Love, Jeffrey M. Sicurello
  • Publication number: 20190000360
    Abstract: Embodiments for synchronous communication between devices in an analyte monitoring system are disclosed. The devices can be in on body device having an analyte sensor and a reader device. The devices can communicate with each other over one or more wireless links. Systems, devices, and methods for establishing synchronization, maintaining synchronization, and reestablishing synchronization are disclosed.
    Type: Application
    Filed: June 28, 2018
    Publication date: January 3, 2019
    Inventors: Jean-Pierre Cole, Hila F. Ralston, Xuandong T. Hua, Theodore J. Kunich
  • Patent number: 10136816
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.
    Type: Grant
    Filed: August 31, 2010
    Date of Patent: November 27, 2018
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Lei He, Gary Alan Hayter, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub
  • Publication number: 20180325434
    Abstract: Methods and devices and systems including a communication module operatively coupled to a data collection module for communicating the stored analyte related data after the analyte related data is stored in the data collection module over a predetermined time period, and a user interface unit configured to communicate with the communication module to receive from the communication module the stored analyte related data in the data collection module over the predetermined time period, and to output information associated with the monitored analyte level, where the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of information associated with the monitored analyte level, or a retrospective analysis mode including limited output of information during the predetermined time period wherein no information related to the monitored analyte level is output during the predetermined time period, are provided.
    Type: Application
    Filed: July 10, 2018
    Publication date: November 15, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Jared Watkin, Martin J. Fennell, Mark Kent Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
  • Publication number: 20180303389
    Abstract: Methods, systems and devices for detecting an analyte sample, determining an analyte concentration associated with the detected analyte sample, storing the determined analyte concentration and a time associated with the determined analyte concentration, retrieving two or more stored analyte concentrations, and determining an adjusted dose level based at least in part on a current dose level and data associated with the two or more retrieved analyte concentrations are provided. For example, adjustments to dosage levels of long-acting insulin may be provided to assist in the management of diabetes and related conditions.
    Type: Application
    Filed: May 25, 2018
    Publication date: October 25, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Mark K. Sloan, Frederic Arbogast, Jean-Pierre Cole, Namvar Kiaie, Jonathan Fern, Lynne K. Lyons, William J. Matievich, JR., Lynn Dixon, Mark P. Jesser, Matthew T. Vogel, Jai Karan, Nathan C. Crouther, Marc B. Taub
  • Publication number: 20180271419
    Abstract: Methods and devices to detect analyte in body fluid are provided. Embodiments include enhanced analyte monitoring devices and systems.
    Type: Application
    Filed: May 21, 2018
    Publication date: September 27, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Jared Watkin, Martin J. Fennell, Mark Kent Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
  • Publication number: 20180256103
    Abstract: Systems, devices and methods are provided for the monitoring and management of an individual's wellness and nutrition using analyte data from an in vivo analyte sensor. Generally, a sensor control device is provided for wear on the body. The sensor control device can include an in vivo analyte sensor for measuring an analyte level in a bodily fluid, an accelerometer for measuring the physical activity level of the subject, as well as communications circuitry for wirelessly transmitting data to a reader device. Furthermore, disclosed herein are embodiments of various graphical user interfaces for displaying analyte metrics on a reader device, comparing the analyte response of various foods and/or meals, modifying daily nutrient recommendations based on analyte metrics and physical activity level measurements, and other features described herein. Additionally, the embodiments disclosed herein can be used to monitor various types of analytes.
    Type: Application
    Filed: February 27, 2018
    Publication date: September 13, 2018
    Inventors: Jean-Pierre Cole, Benjamin J. Feldman, Udo Hoss, Namvar Kiaie, Frederic T. Arbogast
  • Publication number: 20180256116
    Abstract: Methods, devices, systems, and kits are provided that buffer the time spaced glucose signals in a memory, and when a request for real time glucose level information is detected, transmit the buffered glucose signals and real time monitored glucose level information to a remotely located device, process a subset of the received glucose signals to identify a predetermined number of consecutive glucose data points indicating an adverse condition such as an impending hypoglycemic condition, confirm the adverse condition based on comparison of the predetermined number of consecutive glucose data points to a stored glucose data profile associated with the adverse condition, where confirming the adverse condition includes generating a notification signal when the impending hypoglycemic condition is confirmed, and activate a radio frequency (RF) communication module to wirelessly transmit the generated notification signal to the remotely located device only when the notification signal is generated.
    Type: Application
    Filed: May 2, 2018
    Publication date: September 13, 2018
    Inventor: Jean-Pierre Cole
  • Patent number: 10010273
    Abstract: Methods, systems and devices for detecting an analyte sample, determining an analyte concentration associated with the detected analyte sample, storing the determined analyte concentration and a time associated with the determined analyte concentration, retrieving two or more stored analyte concentrations, and determining an adjusted dose level based at least in part on a current dose level and data associated with the two or more retrieved analyte concentrations are provided. For example, adjustments to dosage levels of long-acting insulin may be provided to assist in the management of diabetes and related conditions.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: July 3, 2018
    Assignee: Abbott Diabetes Care, Inc.
    Inventors: Mark K. Sloan, Frederic Arbogast, Jean-Pierre Cole, Namvar Kiaie, Jonathan Fern, Lynne K. Lyons, William Matievich, Jr., Lynn Dixon, Mark P. Jesser, Matthew T. Vogel, Jai Karan, Nathan C. Crouther, Marc B. Taub
  • Publication number: 20180153454
    Abstract: Methods of compensating for ambient temperature using a single temperature sensor, the method comprising detecting a first temperature measurement from a temperature sensor; and determining, with a processor, an ambient-compensated temperature from the first temperature measurement using an offset term. The method may also include receiving a sensor signal from an in vivo analyte sensor; and determining, with a processor, a temperature-compensated analyte sensor signal with the ambient-compensated temperature.
    Type: Application
    Filed: January 17, 2018
    Publication date: June 7, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary A. Hayter, Daniel M. Bernstein, Martin J. Fennell, Michael R. Love, Kenneth J. Doniger, Songbiao Zhang, Mark K. Sloan, Hyun Cho, Theodore J. Kunich, Jean-Pierre Cole, Christopher A. Thomas, Erwin S. Budiman, David L. Li, Royce Cheng, Udo Hoss
  • Patent number: 9980669
    Abstract: Methods and devices for providing application specific integrated circuit architecture for a two electrode analyte sensor or a three electrode analyte sensor are provided. Systems and kits employing the same are also provided.
    Type: Grant
    Filed: November 7, 2012
    Date of Patent: May 29, 2018
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Jean-Pierre Cole, Martin J. Fennell
  • Patent number: 9974472
    Abstract: Methods, devices and systems related providing accurate glucose levels in view of temperatures that may adversely affect glucose value.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: May 22, 2018
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary A. Hayter, Daniel M. Bernstein, Martin J. Fennell, Michael R. Love, Kenneth J. Doniger, Songbiao Zhang, Mark K. Sloan, Hyun Cho, Theodore J. Kunich, Jean-Pierre Cole, Christopher A. Thomas, Erwin S. Budiman, David L. Li, Royce Cheng, Udo Hoss
  • Patent number: 9968306
    Abstract: Methods, devices, systems, and kits are provided that buffer the time spaced glucose signals in a memory, and when a request for real time glucose level information is detected, transmit the buffered glucose signals and real time monitored glucose level information to a remotely located device, process a subset of the received glucose signals to identify a predetermined number of consecutive glucose data points indicating an adverse condition such as an impending hypoglycemic condition, confirm the adverse condition based on comparison of the predetermined number of consecutive glucose data points to a stored glucose data profile associated with the adverse condition, where confirming the adverse condition includes generating a notification signal when the impending hypoglycemic condition is confirmed, and activate a radio frequency (RF) communication module to wirelessly transmit the generated notification signal to the remotely located device only when the notification signal is generated.
    Type: Grant
    Filed: October 21, 2014
    Date of Patent: May 15, 2018
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Jean-Pierre Cole
  • Publication number: 20170086718
    Abstract: Methods, devices, systems, and kits are provided that buffer the time spaced glucose signals in a memory, and when a request for real time glucose level information is detected, transmit the buffered glucose signals and real time monitored glucose level information to a remotely located device, process a subset of the received glucose signals to identify a predetermined number of consecutive glucose data points indicating an adverse condition such as an impending hypoglycemic condition, confirm the adverse condition based on comparison of the predetermined number of consecutive glucose data points to a stored glucose data profile associated with the adverse condition, where confirming the adverse condition includes generating a notification signal when the impending hypoglycemic condition is confirmed, and activate a radio frequency (RF) communication module to wirelessly transmit the generated notification signal to the remotely located device only when the notification signal is generated.
    Type: Application
    Filed: December 13, 2016
    Publication date: March 30, 2017
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Jean-Pierre Cole, Namvar Kiaie
  • Publication number: 20170068533
    Abstract: Embodiments described herein include methods and/or systems for updating a medical device. Embodiments include medical devices which are configured for updates in response to various events including connection of a peripheral device to the medical device, a user initiated event, or based on received recommendations.
    Type: Application
    Filed: November 17, 2016
    Publication date: March 9, 2017
    Inventors: Namvar Kiaie, Jean-Pierre Cole
  • Patent number: 9501272
    Abstract: Embodiments described herein include methods and/or systems for updating a medical device. Embodiments include medical devices which are configured for updates in response to various events including connection of a peripheral device to the medical device, a user initiated event, or based on received recommendations.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: November 22, 2016
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Namvar Kiaie, Jean-Pierre Cole
  • Publication number: 20160140306
    Abstract: Systems, devices, and methods are provided that enable the revision of RF command handling software stored in ROM, and that enable to supplementation of RF command handling software stored in ROM. Examples of the systems, devices, and methods make use of a lookup data structure stored within writable non-volatile memory.
    Type: Application
    Filed: November 18, 2015
    Publication date: May 19, 2016
    Inventors: Xuandong Hua, Jean-Pierre Cole, Martin Fennell, Theodore J. Kunich, Lane Westlund, Arni Ingimundarson
  • Publication number: 20160015267
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.
    Type: Application
    Filed: August 31, 2015
    Publication date: January 21, 2016
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Hung Dinh, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
  • Publication number: 20160015268
    Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.
    Type: Application
    Filed: August 31, 2015
    Publication date: January 21, 2016
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Hung Dinh, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello